These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Macular Atrophy Progression and 7-Year Vision Outcomes in Subjects From the ANCHOR, MARINA, and HORIZON Studies: The SEVEN-UP Study. Brijesh T; Shorya A Am J Ophthalmol; 2016 Feb; 162():200. PubMed ID: 26627044 [No Abstract] [Full Text] [Related]
3. Macular atrophy progression and 7-year vision outcomes in subjects from the ANCHOR, MARINA, and HORIZON studies: the SEVEN-UP study. Bhisitkul RB; Mendes TS; Rofagha S; Enanoria W; Boyer DS; Sadda SR; Zhang K Am J Ophthalmol; 2015 May; 159(5):915-24.e2. PubMed ID: 25640411 [TBL] [Abstract][Full Text] [Related]
4. Macular Morphology and Visual Acuity in the Second Year of the Comparison of Age-Related Macular Degeneration Treatments Trials. Sharma S; Toth CA; Daniel E; Grunwald JE; Maguire MG; Ying GS; Huang J; Martin DF; Jaffe GJ; Ophthalmology; 2016 Apr; 123(4):865-75. PubMed ID: 26783095 [TBL] [Abstract][Full Text] [Related]
6. Neovascular age-related macular degeneration: is it worthwhile treating an eye with poor visual acuity, if the visual acuity of the fellow eye is good? Rasmussen A; Fuchs J; Hansen LH; Larsen M; Sander B; Lund-Andersen H Eye (Lond); 2017 Jun; 31(6):978-980. PubMed ID: 28106891 [No Abstract] [Full Text] [Related]
7. Long-term visual outcome and prognostic factors of Intravitreal anti-vascular endothelial growth factor treatment for retinal angiomatous proliferation. Cho HJ; Lee TG; Han SY; Kim HS; Kim JH; Han JI; Lew YJ; Kim JW Graefes Arch Clin Exp Ophthalmol; 2016 Jan; 254(1):23-30. PubMed ID: 25825231 [TBL] [Abstract][Full Text] [Related]
8. Correlation between neovascular lesion type and clinical characteristics of nonneovascular fellow eyes in patients with unilateral, neovascular age-related macular degeneration. Marsiglia M; Boddu S; Chen CY; Jung JJ; Mrejen S; Gallego-Pinazo R; Freund KB Retina; 2015 May; 35(5):966-74. PubMed ID: 25627089 [TBL] [Abstract][Full Text] [Related]
9. Progression of retinal pigment epithelial atrophy in antiangiogenic therapy of neovascular age-related macular degeneration. Schütze C; Wedl M; Baumann B; Pircher M; Hitzenberger CK; Schmidt-Erfurth U Am J Ophthalmol; 2015 Jun; 159(6):1100-1114.e1. PubMed ID: 25769245 [TBL] [Abstract][Full Text] [Related]
11. Visual outcomes in relation to time to treatment in neovascular age-related macular degeneration. Real JP; Luna JD Acta Ophthalmol; 2016 Dec; 94(8):e803. PubMed ID: 27417383 [No Abstract] [Full Text] [Related]
12. Treatment of wet age-related macular degeneration by ranibizumab in "real life" in France: treatment behaviours and associated visual outcome. Souied EH; Cohen SY; de Pouvourville G; Dupeyron G; Latour E; Ponthieux A; Weber M Acta Ophthalmol; 2015 Mar; 93(2):e179-80. PubMed ID: 25377519 [No Abstract] [Full Text] [Related]
13. Retrospective hospital-based analysis of age-related macular degeneration patterns in India: 5-year follow-up. Sudhalkar A; Sethi V; Gogte P; Bondalapati S; Khodani M; Chhablani JK Indian J Ophthalmol; 2015 Dec; 63(12):899-904. PubMed ID: 26862094 [TBL] [Abstract][Full Text] [Related]
14. Comment on: Peripapillary RNFL thickness in nonexudative versus chronically treated exudative age-related macular degeneration. Ozge G; Ayyildiz O; Mumcuoglu T Can J Ophthalmol; 2016 Feb; 51(1):50. PubMed ID: 26874160 [No Abstract] [Full Text] [Related]
15. Latest Developments in the Management of AMD. Chang A; Schlottmann PG; Chan RVP Asia Pac J Ophthalmol (Phila); 2017; 6(6):477-478. PubMed ID: 29204992 [No Abstract] [Full Text] [Related]
16. PROGRESSION OF MACULAR ATROPHY IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION UNDERGOING ANTIVASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY. Abdelfattah NS; Zhang H; Boyer DS; Sadda SR Retina; 2016 Oct; 36(10):1843-50. PubMed ID: 27135213 [TBL] [Abstract][Full Text] [Related]